<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28394979</identifier>
<setSpec>0717-6341</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Cardona-Arias, Jaiberth Antonio</dc:author>
<dc:author>Carrasquilla-Agudelo, Yoneida Elena</dc:author>
<dc:author>Restrepo-Posada, Deisy Cristina</dc:author>
<dc:description xml:lang="en">INTRODUCTION The screening of neurocysticercosis is complex and immunological methods have varying validity. OBJECTIVE To evaluate the validity of ELISA for antigen and antibody, and EITB for antibody in the screening of neurocysticercosis. METHODS Meta-analysis of diagnostic tests with an ex-ante protocol implemented in five databases with 15 search strategies, ensuring reproducibility in the selection and extraction of information. Sensitivity, specificity, likelihood ratios (LR), diagnostic odds ratio and ROC curve were estimated in MetaDiSc, and predictive values, and Youden index were estimated in Epidat. RESULTS EITB presented sensitivity of 85.7% (95% CI 83.5-87.7), specificity 93.9% (95% CI = 92.7-95.0), PLR 19.6 (95% CI = 8,6-44.6), NLR 0.16 (95% CI = 0.12-0.21), OR diagnostic 136.2 (95% CI = 54.7-342.6) and area under the curve 0.926. In ELISA for antibody sensitivity was 87.5% (95% CI = 86.1-88.8), specificity 92.2% (95% CI = 91.4-93.0), PLR 11.3 (95% CI = 8.45-15.11), NLR 0.15 (95% CI = 0.13-0.18), diagnostic OR 87.4 (95% CI = 60.1-127.1) and area under the curve 0.950. ELISA for antigen showed low diagnostic validity. No differences were found in these parameters by sample, antigen or antibody type. CONCLUSION ELISA for antibodies and EITB have a similar diagnostic value, detection of serum and CSF showed a similar validity.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>2017 Feb </dc:date>
<dc:title xml:lang="es">Validez de tres métodos de inmuno-diagnóstico de neurocisticercosis: revisión sistemática de la literatura con meta-análisis 1960-2014.</dc:title>
<dc:title xml:lang="en">[Validity of three methods for inmuno-diagnostic of neurocysticercosis: systematic review of the literature with meta-analysis 1960-2014].</dc:title>
<dc:publisher>Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
